Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease
FiCP represents a minimally invasive, tract-specific biomarker that mirrors local inflammatory activity and dynamically tracks treatment response in pfCD. Multicenter validation is warranted to define its clinical utility.
Authors
- Chaoyi Lin
- X Wang
- Keyu Qian
- Xia Liu (ORCID: https://orcid.org/0000-0002-9209-0562)
- Yousheng li
- Dan‐dan Ruan (ORCID: https://orcid.org/0000-0001-9611-2979)
- Zi Wang (ORCID: https://orcid.org/0000-0002-3953-0493)
- Ye Zhang (ORCID: https://orcid.org/0000-0002-3494-7206)
- Dongbo Xu
- Yeyi Yang
- Jia Kuang
- Guangyu Wu
- Runqi Wang
- Yanglong Wu
- Dongxing Cao
- Binghua Chen
- Zhe Cui
Institutions
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
- Shanghai Ninth People's Hospital (CN)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1111/apt.70600
- Primary Topic
- Anorectal Disease Treatments and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00